Skip to main content

Advertisement

ADVERTISEMENT

news

Conference Insider
03/25/2022
Nina Shah, MD, presents pomalidomide as a superior treatment versus carfilzomib for patients with MM during the virtual Great Debates & Updates in Hematologic Malignancies.
Nina Shah, MD, presents pomalidomide as a superior treatment versus carfilzomib for patients with MM during the virtual Great Debates & Updates in Hematologic Malignancies.
Nina Shah, MD, presents...
03/25/2022
Oncology
Conference Insider
03/23/2022

Emily Bader

Emily Bader
Peter Martin, MD, discusses how to approach MCL, including what’s been learned so far and what’s to be expected, at the virtual Great Debates & Updates in Hematologic Malignancies.
Peter Martin, MD, discusses how to approach MCL, including what’s been learned so far and what’s to be expected, at the virtual Great Debates & Updates in Hematologic Malignancies.
Peter Martin, MD, discusses how...
03/23/2022
Oncology
Conference Insider
03/23/2022

Alexa Stoia

Alexa Stoia
John Leonard, MD, presents novel data with CAR-T therapies in upfront, second line DLBCL during the virtual Great Debates & Updates in Hematologic Malignancies.
John Leonard, MD, presents novel data with CAR-T therapies in upfront, second line DLBCL during the virtual Great Debates & Updates in Hematologic Malignancies.
John Leonard, MD, presents novel...
03/23/2022
Oncology
Conference Insider
03/01/2021
During the virtual Great Debates & Updates in Hematologic Malignancies, Dr Pemmaraju discussed new therapies for myeloproliferative neoplasms (MPNs) with a focus on CMML.
During the virtual Great Debates & Updates in Hematologic Malignancies, Dr Pemmaraju discussed new therapies for myeloproliferative neoplasms (MPNs) with a focus on CMML.
During the virtual Great Debates...
03/01/2021
Oncology
News
07/18/2020
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
At the virtual Great Debates &...
07/18/2020
Oncology
News
03/23/2019
John P. Leonard, MD, presented an update on upfront and maintenance therapy in follicular lymphoma at the 2019 Great Debates and Updates in Hematologic Malignancies meeting.
John P. Leonard, MD, presented an update on upfront and maintenance therapy in follicular lymphoma at the 2019 Great Debates and Updates in Hematologic Malignancies meeting.
John P. Leonard, MD, presented...
03/23/2019
Oncology
News
04/26/2018
Suzanne Lentzsch, MD, PhD, presented data that three drug regimens should be considered standard for myeloma salvage therapy.
Suzanne Lentzsch, MD, PhD, presented data that three drug regimens should be considered standard for myeloma salvage therapy.
Suzanne Lentzsch, MD, PhD,...
04/26/2018
Oncology

Advertisement